| P50 | author | Tomas Kirchhoff | Q47162464 |
| P2093 | author name string | D Polsky | |
| | B McLellan | |
| | R M Cymerman | |
| | L A Penn | |
| | P V Gumaste | |
| P2860 | cites work | Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 |
| | Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining | Q24630418 |
| | Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status | Q24802534 |
| | Second cancer following cancer of the female breast in Denmark, 1943-80. | Q50549986 |
| | Malignant melanoma and breast carcinoma: a bidirectional correlation. | Q51129513 |
| | BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. | Q52537650 |
| | Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. | Q52544495 |
| | Assessing BRCA carrier probabilities in extended families. | Q52997805 |
| | Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin. | Q54521566 |
| | Second primary neoplasms following breast cancer in Saarland, Germany, 1968–1987 | Q57192903 |
| | Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations | Q57266547 |
| | Cancer risk in women with previous breast cancer | Q57560334 |
| | BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma | Q57744383 |
| | Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program | Q57903119 |
| | BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers | Q57903140 |
| | Risk of second cancer among women with breast cancer | Q58006639 |
| | Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours | Q59689071 |
| | The genetic attributable risk of breast and ovarian cancer | Q71089065 |
| | Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group | Q73108544 |
| | Increased risk of second cancers following breast cancer: role of the initial treatment | Q74244606 |
| | Cancer risks in BRCA1 carriers: time for the next generation of studies | Q74801146 |
| | Multiple primary cutaneous melanomas in Li-Fraumeni syndrome | Q83457172 |
| | Second cancer following cancer of the breast in Connecticut, 1935-82 | Q93675643 |
| | Cancer susceptibility and the functions of BRCA1 and BRCA2 | Q28217784 |
| | RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2 | Q28257035 |
| | Characterization of BRCA1 and BRCA2 mutations in a large United States sample | Q28383993 |
| | A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families | Q28384206 |
| | Brca1 controls homology-directed DNA repair | Q29614844 |
| | BRCA2 is required for homology-directed repair of chromosomal breaks | Q29618799 |
| | Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation | Q33558779 |
| | Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences | Q34081887 |
| | BRCA1 and BRCA2: 1994 and beyond | Q34345297 |
| | Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer | Q34417238 |
| | BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer | Q34493362 |
| | Cancer risks in BRCA2 mutation carriers | Q34504452 |
| | Cancer Incidence in BRCA1 mutation carriers | Q34527264 |
| | Common variants of DNA repair genes and malignant melanoma | Q34585088 |
| | Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium | Q34724404 |
| | Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. | Q35248795 |
| | A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO | Q35445946 |
| | The role of the BRCA1 tumor suppressor in DNA double-strand break repair | Q36299256 |
| | The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families | Q37364392 |
| | Systemic therapy options in BRCA mutation-associated breast cancer | Q38025991 |
| | Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers | Q38317651 |
| | Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. | Q38469992 |
| | Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer | Q38490313 |
| | Second primary cancers in breast cancer patients in Slovenia | Q38503822 |
| | Malignant melanoma and carcinoma of the breast | Q39944241 |
| | BRCA1 and BRCA2 families and the risk of skin cancer | Q42476456 |
| | Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas | Q42678425 |
| | Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. | Q43073144 |
| | Genetic susceptibility in familial melanoma from northeastern Italy. | Q43073623 |
| | Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers | Q43843055 |
| | Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy | Q44665315 |
| | Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. | Q45970196 |
| | BRCA mutations and risk of prostate cancer in Ashkenazi Jews | Q47637460 |
| | On the use of familial aggregation in population-based case probands for calculating penetrance | Q50109259 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | skin cancer | Q192102 |
| | BRCA1 Mutation | Q28444960 |
| P304 | page(s) | 1498-1506 | |
| P577 | publication date | 2015-04-29 | |
| P1433 | published in | British Journal of Dermatology | Q4970191 |
| P1476 | title | Skin cancer risk in BRCA1/2 mutation carriers | |
| P478 | volume | 172 | |